Literature DB >> 19559953

Cervical vestibular evoked myogenic potentials (cVEMPs) in patients with superior canal dehiscence syndrome (SCDS).

Rachel E Roditi1, Robert W Eppsteiner, Todd B Sauter, Daniel J Lee.   

Abstract

OBJECTIVE: To determine the usefulness of both amplitude and threshold data from tone-burst cervical vestibular evoked myogenic potential (cVEMP) testing for the evaluation of superior canal dehiscence syndrome (SCDS). STUDY
DESIGN: Case series with chart review. SUBJECTS AND METHODS: Sixty-seven patients underwent cVEMP testing. We correlated mean tone burst cVEMP amplitude and threshold data with temporal bone CT findings. Patients were excluded for Ménière's disease, middle ear disease, or otologic surgery.
RESULTS: Superior canal dehiscence patients had higher mean cVEMP amplitudes (SCDS 173.8 microV vs non-SCDS 69.7 microV, P=0.031) and lower mean thresholds (SCDS 72.8 dB nHL vs non-SCDS 80.9 dB nHL) at 500 Hz.
CONCLUSION: Patients with SCDS have larger amplitudes and lower thresholds on cVEMP testing at 500 Hz. This study supports the utility of tone burst cVEMPs for the evaluation of SCDS and is one of few large single-center studies to establish normative data.

Entities:  

Mesh:

Year:  2009        PMID: 19559953     DOI: 10.1016/j.otohns.2009.03.012

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Transmastoid repair of superior semicircular canal dehiscence.

Authors:  Yi Chen Zhao; Thomas Somers; Joost van Dinther; Robby Vanspauwen; Jacob Husseman; Robert Briggs
Journal:  J Neurol Surg B Skull Base       Date:  2012-08

2.  Toward Optimizing cVEMP: 2,000-Hz Tone Bursts Improve the Detection of Superior Canal Dehiscence.

Authors:  Kimberley S Noij; Barbara S Herrmann; John J Guinan; Steven D Rauch
Journal:  Audiol Neurootol       Date:  2019-01-24       Impact factor: 1.854

3.  Practice guideline: Cervical and ocular vestibular evoked myogenic potential testing: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Terry D Fife; James G Colebatch; Kevin A Kerber; Krister Brantberg; Michael Strupp; Hyung Lee; Mark F Walker; Eric Ashman; Jeffrey Fletcher; Brian Callaghan; David S Gloss
Journal:  Neurology       Date:  2017-11-01       Impact factor: 9.910

4.  Superior canal dehiscence length and location influences clinical presentation and audiometric and cervical vestibular-evoked myogenic potential testing.

Authors:  Marlien E F Niesten; Leena M Hamberg; Joshua B Silverman; Kristina V Lou; Andrew A McCall; Alanna Windsor; Hugh D Curtin; Barbara S Herrmann; Wilko Grolman; Hideko H Nakajima; Daniel J Lee
Journal:  Audiol Neurootol       Date:  2014-01-09       Impact factor: 1.854

5.  Power reflectance as a screening tool for the diagnosis of superior semicircular canal dehiscence.

Authors:  Gabrielle R Merchant; Christof Röösli; Marlien E F Niesten; Mohamad A Hamade; Daniel J Lee; Melissa L McKinnon; Cagatay H Ulku; John J Rosowski; Saumil N Merchant; Hideko Heidi Nakajima
Journal:  Otol Neurotol       Date:  2015-01       Impact factor: 2.311

6.  Can Wideband Tympanometry Be Used as a Screening Test for Superior Semicircular Canal Dehiscence?

Authors:  Emine Demir; Nazife Nur Afacan; Metin Celiker; Fatma Beyazal Celiker; Mehmet Fatih İnecikli; Suat Terzi; Engin Dursun
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-11-22       Impact factor: 3.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.